FWFangqin Wu

Fangqin Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fangqin Wu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jinhua Yang

    Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    1 shared publication
  • Longxian Cheng

    Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Dadao, Wuhan 430022, China

    1 shared publication
  • Meian He

    Huazhong University of Science and Technology

    1 shared publication
  • Qiang Wen

    Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Dadao, Wuhan 430022, China

    1 shared publication
  • Tangchun Wu

    Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

    1 shared publication
  • Wencai Zhang

    The First Affiliated Hospital of Zhengzhou University, China; Academy of Medical Sciences of Zhengzhou University, China

    1 shared publication

Latest Publications

  • Open Access

    Associations between Variants in IL-33/ST2 Signaling Pathway Genes and Coronary Heart Disease Risk

    by Fangqin Wu, Mei'An He, Qiang Wen, Wencai Zhang, Jinhua Yang, Xiaomin Zhang, Tangchun Wu, Longxian Cheng

    The IL-33/ST2 signaling pathway plays an important role in coronary artery disease (CHD); however, few studies have explored how variants in IL-33/ST2 genes influence CHD risk. Here, we examined the association between genetic variants in IL-33, ST2, and IL-1RAcP of the IL-33/ST2 axis and the risk of CHD. We conducted a case-controlled study with 1146 CHD cases and 1146 age- and sex-frequency-matched controls. Twenty-eight single nucleotide polymorphisms (SNPs) in IL-33, ST2, and IL-1RAcP were genotyped by Sequenom MassArray and TaqMan assay. Logistic regression was used to analyze these associations. The SNP rs4624606 in IL-1RAcP was nominally associated with CHD risk. The AA genotype was associated with a 1.85-fold increased risk of CHD (95% confidence interval (CI) = 1.01–3.36; p = 0.045) compared to the TT genotype. Further analysis showed that AA carriers also had a higher risk of CHD than TT + TA carriers (odds ratio (OR) = 1.85; 95% CI = 1.85–3.35; p = 0.043). However, no significant association was observed between variants in IL-33/ST2 genes and CHD risk. Further studies are needed to replicate our results in other ethnic groups with larger sample size.